The pharmaceutical industry is continuously evolving, with increasing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, stands as copyrightple of this trend. To address this demand, US-based manufacturing services are gaining traction. These companies offer a wide-ranging suite of services, from res